Astem-103

N/A

Report date: 2026/01/05 14:26:46

Base Information

Drug NameAstem-103
Drug Alias NameAstem-103人脐带间充质干细胞（上海昂昇生物医药科技有限公司）Astem-103Astem103
ClassificationCell and gene therapy > Cell therapy > Stem cell therapy > Mesenchymal stem cells therapyCell and gene therapy > Cell therapy > Stem cell therapy > Umbilical cord stem cell therapy
Mechanisms of ActionStem cell replacements
TargetsNot applicable
Therapy Area/IndicationsInflammatory Bowel Diseases
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaPreclinical
Originator CompaniesShanghai Angsheng Biomedical Technology Co Ltd
China Registration ClassN/A

Develop Information

Active CompaniesShanghai Angsheng Biomedical Technology Co Ltd
Inactive CompaniesN/A
Active IndicationsInflammatory Bowel Diseases
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A